Emami Limited — PPTs, 04-02-2026: Investor Presentation

Emami delivered a strong Q3FY26! Revenue from operations jumped 10% YoY to ₹1,152 Cr. Domestic business grew 11% (9% volume), while international sales climbed 9%. Profit After Tax surged 15% to ₹319 Cr. EBITDA rose 13% to ₹384 Cr, expanding margins by 110 bps to 33.4%.

Growth was fueled by purposeful innovation, premiumization, and a robust omnichannel strategy. Key launches included Kesh King Gold Advanced Hair Growth Serum, BoroPlus Lip Balm, and new Zandu wellness tablets. Strategic subsidiaries like The Man Company and Brillare Science (with Rosemary Oil Shots) clocked 31% growth. Organized channels now contribute 32% of year-to-date revenues. The board declared a second interim dividend of ₹6/share, totaling ₹10/share for nine months.

Management credits resilient brands despite early GST 2.0 hiccups. Focus remains on strengthening core brands, exploring new growth avenues, and disciplined execution for sustainable profitability. Quick commerce doubled sales, now 20% of e-commerce.